Wegovy Clicks 1.7: What That Number on Your Pen Means

You're mid-titration: what 1.7 clicks actually represents

Picture the moment: you've been on Wegovy for a few months, you've come through the early doses, and now the pen is set to 1.7. It's a specific, deliberate point in the journey, not a rounding error, not an unusual instruction. The Wegovy titration schedule runs 0.25mg, 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg, with each dose typically held for about four weeks. The 1.7mg stage is the penultimate step before reaching the licensed maintenance dose. If you want to see where 1.7mg sits in relation to the full picture, the Wegovy dose overview maps out each stage clearly.

The NHS patient guidance on semaglutide confirms this schedule, and the principle behind it is straightforward: moving through the doses gradually gives your system time to adapt, particularly your digestive system. The side effects that tend to catch people off guard (nausea, bloating, changes in bowel habit) are most noticeable at transitions. Holding at 1.7mg before stepping to 2.4mg is protective, not a delay for its own sake.

It's worth knowing, too, that 1.7mg is not a half-measure. At this stage, most people are already noticing meaningful changes in appetite. That said, if you're curious about how Wegovy affects appetite specifically, the mechanism behind it is worth understanding on its own terms.

Why the click system matters, and why 1.7 is not the same as 2.4

The click-based dosing on Wegovy pens is designed to make each weekly injection reproducible. You dial to the correct number, confirm it, and inject, there's no measuring, no drawing up from a vial. One click equals one milligram on the standard Wegovy pen, so 1.7 clicks is precisely 1.7mg. The Wegovy clicks and dosage guide explains the mechanics in more detail for anyone who wants to be sure they're reading their pen correctly.

The reason it matters to distinguish 1.7mg from the 2.4mg maintenance dose is clinical, not just numerical. Appetite suppression deepens as the dose increases, and so does the likelihood of gastrointestinal side effects. Your prescriber will typically want to know how you tolerated 1.0mg before moving you to 1.7mg, and then how you're tolerating 1.7mg before any further increase. If tolerability at this stage is a concern, questions about whether to increase your Wegovy dose are exactly the kind of thing to raise with your clinical team rather than deciding independently.

The NHS's patient-facing information on semaglutide is a useful reference for what to expect at each stage, the NHS semaglutide medicine guide covers common side effects, how to take the injection, and what to report to a healthcare professional.

Side effects to know at the 1.7mg stage, and when to seek help

Feeling a little uncertain about a dose change is completely normal. Many people find the jump to 1.7 clicks brings a brief resurgence of the nausea or loose stools they thought they'd left behind at lower doses. This usually settles within a week or two as the body adjusts. Common effects across the semaglutide dose range include nausea, vomiting, constipation, diarrhoea, acid reflux, and fatigue, none of them pleasant, but most of them temporary and manageable with small practical adjustments (eating slowly, smaller portions, avoiding very fatty meals).

There are situations that call for prompt medical attention rather than waiting it out. Severe, persistent stomach pain that radiates towards the back (with or without vomiting) should be assessed urgently, as this can be a sign of pancreatitis, a known but uncommon risk with GLP-1 medicines. The MHRA has highlighted this specifically in its safety guidance; the Yellow Card scheme lets patients report any suspected side effects directly to the regulator, which is worth doing if something feels wrong. Signs of a serious allergic reaction, gallbladder pain, or significant dehydration from vomiting or diarrhoea also warrant same-day contact with a healthcare professional.

The full detail on what to watch for, and how to distinguish a side effect that needs attention from one that just needs time, sits in the Patient Information Leaflet that comes with your pen. Read it.

Getting your next step right: talking to a prescriber

If you're at 1.7mg and wondering whether you're on track (whether your progress is what it should be, whether the side effects are typical, whether 2.4mg is the right next move) that conversation belongs with a prescriber. The 1.7mg Wegovy click guide covers the dose in more detail, and for anyone approaching the end of their titration and thinking about what long-term treatment looks like, our Wegovy overview is a useful place to build that broader picture.

If you don't currently have clinical support and you're sourcing treatment privately, it's worth checking that your pharmacy holds a valid GPhC registration, verifiable at the GPhC pharmacy register. At nume, every repeat order involves a fresh clinical review before anything is dispensed. If you'd like that kind of oversight, you're welcome to speak to our prescribers about where you are in your treatment.